We are live on ! Find out more
GALT icon

Galectin Therapeutics

79 hedge funds and large institutions have $26.8M invested in Galectin Therapeutics in 2024 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 21 increasing their positions, 18 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

225% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 4

24% more capital invested

Capital invested by funds: $21.6M → $26.8M (+$5.17M)

17% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 18

8% more funds holding

Funds holding: 7379 (+6)

0.34% more ownership

Funds ownership: 15.32%15.65% (+0.34%)

29% less call options, than puts

Call options by funds: $3.89M | Put options by funds: $5.46M

Holders
79
Holders Change
+6
Holders Change %
+8.22%
% of All Funds
1.13%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
13
Increased
21
Reduced
18
Closed
4
Calls
$3.89M
Puts
$5.46M
Net Calls
-$1.57M
Net Calls Change
-$3.8M